Covid drug.

Covid drug.

26-01-2021PHIL NOBLE

Spanish pharmaceutical company PharmaMar said this morning the peer review journal Science has published a paper that confirms its drug Plitidepsin has a "potent preclinical efficacy" against the COVID-19.

A study carried out in vitro and in vivo by a team of scientists in New York, San Francisco and Paris showed the drug leads to a reduction of viral replication, resulting in a 99% reduction of viral loads in the lungs of plitidepsin-treated animals, the Science paper reported, according to a PharmaMar statement.

"We believe that our data and the initial positive results from PharmaMar’s clinical trial suggests that plitidepsin should be strongly considered for expanded clinical trials for the treatment of COVID-19,” Science said.


The content of comment is the opinion of users and netizens and not of

Comments contrary to laws, which are libellous, illegal or harmful to others are not permitted'); - reserves the right to remove any inappropriate comments.


Please remember that you are responsible for everything that you write and that data which are legally required can be made available to the relevant public authorities and courts; these data being name, email, IP of your computer as well as information accessible through the systems.

* Mandatory fields

Currently there are no comments.